These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33038723)

  • 1. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
    Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
    Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
    Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
    Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
    Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
    J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
    Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
    J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cancer development in patients with leukoplakia--clinicopathological factors affecting outcome.
    Liu W; Shi LJ; Wu L; Feng JQ; Yang X; Li J; Zhou ZT; Zhang CP
    PLoS One; 2012; 7(4):e34773. PubMed ID: 22514665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
    Thomson PJ; Goodson ML; Smith DR
    J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
    Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
    J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of nomograms for predicting cancer risk in oral leukoplakia and oral lichen planus.
    Adeoye J; Su YX
    Oral Dis; 2024 Jul; 30(5):3039-3051. PubMed ID: 38009867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up studies in oral leukoplakia.
    Bánóczy J
    J Maxillofac Surg; 1977 Feb; 5(1):69-75. PubMed ID: 265354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation of oral leukoplakia: a follow-up study.
    Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
    Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.
    Brouns E; Baart J; Karagozoglu Kh; Aartman I; Bloemena E; van der Waal I
    Oral Dis; 2014 Apr; 20(3):e19-24. PubMed ID: 23521625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between clinical and histopathological characteristics in oral leukoplakia.
    Evren I; Brouns ER; Poell JB; Wils LJ; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Mar; 29(2):696-706. PubMed ID: 34601770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of regular follow-up of oral leukoplakia for early detection of malignant transformation.
    Evren I; Najim AM; Poell JB; Brouns ER; Wils LJ; Peferoen LAN; Brakenhoff RH; Bloemena E; van der Meij EH; de Visscher JGAM
    Oral Dis; 2024 Jul; 30(5):2991-3003. PubMed ID: 37936517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical determinants of malignant transformation in oral epithelial dysplasia.
    Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
    Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.